mAbxience

Activity by year

20192020202120222023202420252026

ContractNew facility

Feb 21, 2020NEW FACILITYGarín, Buenos Aires, Argentina$40.0M50 jobsops 21 Feb 2020
mAbxience opens $40M biosimilar antibody plant in Garín, Argentina
mAbxience, part of Insud Pharma, inaugurated a new biosimilar monoclonal antibody production plant in Garín, Buenos Aires, Argentina. The $40 million facility doubles the company's production capacity and created 50 new jobs.
mAbxience Insud Pharma partner #Medical Devices insudpharma.com
Aug 17, 2019CONTRACTGarín, Argentina, Argentina
mAbxience agrees to produce AstraZeneca COVID-19 vaccine in Argentina
mAbxience entered into an agreement with AstraZeneca to produce the COVID-19 vaccine at its Garín plant in Argentina. The active ingredient will be sent to Mexico for filling, with over 200 million doses supplied to Latin America.
mAbxience AstraZeneca customer #Medical Devices chemopharmaceuticals.com

Site	Largest	Latest
Garín, Argentina	$40.0M	2020-02-21

Customers

Loading…